Extended report: Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis

Objectives To investigate how the genetic susceptibility gene DIO2 confers risk to osteoarthritis (OA) onset in humans and to explore whether counteracting the deleterious effect could contribute to novel therapeutic approaches.